A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
Novartis
Novartis
Novartis
Novartis
Novartis
Baylor College of Medicine
Novartis
American University of Beirut Medical Center
Hospices Civils de Lyon
European LeukemiaNet
Novartis
Novartis
Medical College of Wisconsin
Gruppo Italiano Malattie EMatologiche dell'Adulto
M.D. Anderson Cancer Center